This session explores the importance of culturally relevant and patient-centric strategies, and how partnerships with trusted advocacy and community influencers can help break down barriers for historically underserved communities. Panelists will also discuss new innovative treatment areas, like mRNA technology, for cancer prevention and highlight the importance of patient-centered care in the development of new therapies. They will address the challenges of developing new treatments and cures, including how to maximize the impact of treatments while ensuring access and equity for all.